1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. US AI IN PRECISION MEDICINE BY TECHNOLOGY
4.1. Machine Learning
4.2. Natural Language Processing (NLP)
4.3. Deep Learning
4.4. Big Data Analytics
4.5. Others
5. US AI IN PRECISION MEDICINE BY APPLICATION
5.1. Drug Discovery and Development
5.2. Oncology
5.3. Genetic Testing
5.4. Rare Diseases
5.5. Infectious Diseases
5.6. Others
6. US AI IN PRECISION MEDICINE BY END-USER
6.1. Pharmaceutical and Biotechnology Companies
6.2. Research Institutes and Academic Centers
6.3. Healthcare Providers
6.4. Others
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Market Share Analysis
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Competitive Dashboard
8. COMPANY PROFILES
8.1. NVIDIA Corporation
8.2. Illumina, Inc.
8.3. Tempus AI, Inc.
8.4. Guardant Health, Inc.
8.5. Ibex Medical Analytics Ltd.
8.6. Prenosis, Inc.
8.7. Alphabet Inc.
8.8. GE HealthCare Technologies Inc.
8.9. ConcertAI, LLC
8.10. BioXcel Therapeutics, Inc.